METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS

This application describes methods of inhibiting APOL1 and treating APOL1-mediated diseases comprising administering Compound I and/or a pharmaceutically acceptable salt thereof.The application also describes pharmaceutical compositions comprising Compound I and/or a pharmaceutically acceptable salt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MALLALIEU, Navita, HARE, Brian J, WU, Shu-Pei, EGBUNA, Ifeatu, KRUG, Alexander Wolfgang
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This application describes methods of inhibiting APOL1 and treating APOL1-mediated diseases comprising administering Compound I and/or a pharmaceutically acceptable salt thereof.The application also describes pharmaceutical compositions comprising Compound I and/or a pharmaceutically acceptable salt thereof.